Unraveling the molecular mechanism underlying the anticancer activity of CISD2/NAF-1^44-67

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• NAF-1^44-67 is a peptide derived from CISD2/NAF-1 that selectively targets cancer cells.
• It induces apoptosis and ferroptosis in cancer cells and shrinks tumors in vivo without side effects.
• The mechanism of NAF-1^44-67's intracellular activity was previously unknown.

Purpose of the Study:

• To elucidate the molecular mechanism by which NAF-1^44-67 exerts its anticancer effects.
• To investigate the interaction of NAF-1^44-67 with its target protein CISD2/NAF-1 within cancer cells.
• To compare the activity of NAF-1^44-67 with a related peptide, mitoNEET (mNT^19-42), and assess the role of dimerization.

Main Methods:

• Investigated the interaction between NAF-1^44-67 and the CISD2/NAF-1 protein in cancer cells.
• Analyzed the effect of NAF-1^44-67 on the homodimeric structure of CISD2/NAF-1.
• Compared the anticancer activity of monomeric and dimeric forms of NAF-1^44-67.
• Evaluated the activity of mitoNEET (mNT^19-42) against cancer cells.

Main Results:

• NAF-1^44-67 targets and disrupts the homodimeric structure of CISD2/NAF-1 in cancer cells.
• Dimeric forms of NAF-1^44-67 exhibited enhanced anticancer activity compared to the monomeric form.
• The related peptide mitoNEET (mNT^19-42) showed no cancer-killing activity.

Conclusions:

• NAF-1^44-67's anticancer mechanism involves the disruption of CISD2/NAF-1 homodimers.
• Dimerization of NAF-1^44-67 potentiates its efficacy.
• These findings advance the understanding of NAF-1^44-67's biological activity and support its development as a potential anticancer therapeutic.